Please login to the form below

Not currently logged in

Pharmaceutical Market Europe (PME)

PME is a monthly print and digital title written by experienced journalists and high-profile pharma and healthcare experts. The magazine provides insights and offers solutions to the issues that keep industry leaders awake at night.

From the latest developments in cancer treatments and the strategies behind them to new marketing and commercialisation models and the regulations that underpin the fabric of the sector – PME's got it covered.

PME is a trusted source for decision makers and influencers in pharma and healthcare who, through the practical and accessible content, have the knowledge to tackle whatever comes their way.

From: Regulatory

J&J puts pressure on rivals with new Erleada okay in prostate cancer

Johnson and Johnson logoFDA previously granted priority review in this indication

From: Research

Bluebird Bio reveals further encouraging data for CALD gene therapy

Bluebird BioStudy shows continued benefit in treatment of rare disease

From: Regulatory

Takeda’s HAE drug Takhzyro backed by NICE

New treatment option for rare, hereditary disease

From: Healthcare

Distribution of Novartis’ generic Zantac halted due to carcinogen concerns

Sandoz NovartisRanitidine medicines found to contain cancer-causing substance


Pharmaceutical Market Europe - September 2019

Patient vs Pharma, this is the situation which the industry dreads, but in 2019 has become a reality on several fronts: when patients see pharma not as a friend, but a foe.

Pharmaceutical Market Europe (PME) magazine is also available on the iPhone/iPad as a free app

Editor - Iona Everson

Have your say...

AZ shares spike on good second quarter led by cancer drugs

Soriot expecting no fewer than five of AZ’s new drugs to hit blockbuster status this year

AstraZeneca AZ

'Nothing about us without us'

Why patient engagement is essential throughout the entire product life cycle

Meike Wenzel

Edging Evolution

You don’t have to wait for your business to evolve

darwins medicine

Featured jobs

Subscribe to our email news alerts


Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

Report: Customer experience, shaping digital healthcare
In this issue of ‘Perspective’ we speak with industry experts to learn about the world of digital healthcare, and how pharma is beginning to utilise these modern technologies to enhance...
Encouraging signs in biomarker R&D
The cancer immunotherapy firms ramping-up biomarker R&D...
Programmatic methodology and why you should be using it
What is it? How does it work? Why is everyone talking about it? By Richard Webb - Associate Director...